Technologies and operational methods for the development and manufacturing of drug products, including biologics and protein-based therapeutics, are continually changing. Reproducing drugs reliably at commercial scale is increasingly sophisticated, complex and potentially extremely costly. Drug product manufacturers are under constant pressure to deliver the best treatment as quickly as possible at an appropriate price―and get reimbursed equitably for their efforts. And, of course, safety remains at the top of the priority list.

CPC Biotech delivers light weight, non-spill, worry-free bioprocessing

With drug manufacturers’ objectives of providing safe, cost-effective and shortened time-to-market, CPC’s Biotech bioprocessing engineers are deeply familiar with how SUS use requires media handling that is of the highest quality, assures sterility, and delivers reliability. Our team, including materials scientists, design engineers and applications engineers, exclusively focuses on bioprocessing connectors, resulting in a robust portfolio of genderless, sterile and steam-in-place connects and disconnects expressly for drug development and production.

CPC Biotech sterile connectors, such as AseptiQuik® and Quattroflow® are a critical component to bring together single-use assemblies, while maintaining a sterile fluid pathway. They are precision engineered to connect one processing stream to another―such as a container to a sampling line, media to a vessel or a filtration process to a filling line.